Clinical Trial Update: Se-Methyl-Seleno-L-Cysteine, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating Se-Methyl-Seleno-L-Cysteine with Rituximab, Ifosfamide, Carboplatin, and Etoposide for relapsed or treatment-refractory di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)
• IFOSFAMIDE (IFOSFAMIDE)
• Rituximab (rituximab)
• Se-Methyl-Seleno-L-Cysteine (Se-Methyl-Seleno-L-Cysteine)

Snippet

Sponsor: Cancer Research UK | Conditions: Lymphoma | Phase 1, Phase 2 | Status: WITHDRAWN